AstraZeneca starts trial of COVID-19 antibody treatment

mAbs mimic natural antibodies generated in the body to fight off infection and can be synthesised in the laboratory to treat diseases in patients. Current uses include treatment of some types of cancers.

U.S. infectious diseases expert Anthony Fauci has called them “almost a sure bet” against COVID-19, and AstraZeneca in June received $23.7 million in funding from U.S. government agencies to advance development of antibody-based treatments for COVID-19.

Though vaccines are at the heart of the long-term fight against the pandemic, alternative treatments are also being advanced, and the United States on Sunday authorized use of recovered COVID-19 patients’ plasma to treat those who are ill. The Financial Times reported at the weekend that President Donald Trump’s administration was considering a fast-tracked approval of AstraZeneca’s COVID-19 vaccine before November’s elections.

Reporting by Pushkala Aripaka and Aakash Jagadeesh Babu in Bengaluru; Editing by Shailesh Kuber and Patrick Graham

あ、かた、たあ、や、ちみ

Under President Trump’s leadership, the U.S. government has ordered 300 million doses of a potential COVID-19 vaccine being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October!

preparing to get rich?

شرح بسيط في التداول في الخيارات الثنائية هنا على الرابط٠...للاشخاص المهتمين بربح من الانترنات

Best wishes 🇳🇵🙏🏻🙏🏻🙏🏻

I can't wait till my insurance doesn't cover this.

👍👍👍👋👋👋🥇

'Worst cocktail ever!'

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Coronavirus: AstraZeneca starts trial of COVID-19 antibody treatmentBritish drugmaker AstraZeneca has started early testing of an antibody-based treatment for the prevention and treatment of COVID-19, the company said on Tuesday. I hope all biden followers are the first to get in it for the vaccine.
Source: NBCNews - 🏆 10. / 86 Read more »

FDA Authorizes Use of Plasma From Recovered Patients to Treat COVID-19The authorization makes it easier for some patients to obtain the treatment but is not the same as full FDA approval
Source: TIMEHealth - 🏆 121. / 63 Read more »

HHS Chief Alex Azar Defends Authorization Of Plasma To Treat COVID-19NPR's Ari Shapiro talks with Health and Human Services Secretary Alex Azar about the Food and Drug Administration allowing the use of convalescent plasma to treat COVID-19. Azar re: Trump's accusations: 'Thank you, Sir! May I have another?' That's up to the front line physicians in consultation with their patients to decide specific treatment modalities... I have a friend whose sister’s dire COVID case turned around after she received convalescent plasma. That’s all the data I have but it is certainly compelling
Source: NPRHealth - 🏆 144. / 63 Read more »

Trump and FDA announce new method to treat hospitalized COVID-19 patientsThe president said the new, expedited method of treatment has led to a reduced mortality rate by 35 percent in coronavirus patients. Shoveling them into a hole “Trump down 9+ pts so he deploys desperate childish prank to pre-empt upcoming Biden interview. As usual, he fails.” LOL.. who’s stupid enough to trust anything Trump and his administration says?
Source: Newsweek - 🏆 468. / 52 Read more »